3/24
11:12 am
opk
Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target [Yahoo! Finance]
Low
Report
Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target [Yahoo! Finance]
3/24
06:13 am
opk
Previvor Edge Expands Platform to Deliver Personalized Clinical-Grade Cancer Risk Profiles and Interactive Prevention Plans [TheStreet.com]
Low
Report
Previvor Edge Expands Platform to Deliver Personalized Clinical-Grade Cancer Risk Profiles and Interactive Prevention Plans [TheStreet.com]
3/23
09:35 pm
opk
Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage? [Yahoo! Finance]
Low
Report
Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage? [Yahoo! Finance]
3/20
06:20 pm
opk
Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy [Yahoo! Finance]
Low
Report
Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy [Yahoo! Finance]
3/16
01:58 pm
opk
“CNBC CURES: DEFYING RARE DISEASE” WITH BECKY QUICK TO PREMIERE ON THURSDAY, MARCH 19 AT 7PM ET [CNBC]
Low
Report
“CNBC CURES: DEFYING RARE DISEASE” WITH BECKY QUICK TO PREMIERE ON THURSDAY, MARCH 19 AT 7PM ET [CNBC]
3/11
05:27 pm
opk
GeneDx Holdings Corp. (WGS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
GeneDx Holdings Corp. (WGS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
05:26 pm
opk
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing [Yahoo! Finance]
Low
Report
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing [Yahoo! Finance]
3/10
08:46 am
opk
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C [Yahoo! Finance]
Low
Report
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C [Yahoo! Finance]
3/9
08:42 am
opk
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership [Yahoo! Finance]
Low
Report
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership [Yahoo! Finance]
3/2
10:56 am
opk
OPKO Health (OPK) had its price target lowered by Barrington Research from $2.25 to $1.50. They now have an "outperform" rating on the stock.
Medium
Report
OPKO Health (OPK) had its price target lowered by Barrington Research from $2.25 to $1.50. They now have an "outperform" rating on the stock.
2/27
08:00 am
opk
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
Low
Report
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
2/27
01:35 am
opk
OPKO Health Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
OPKO Health Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
09:06 pm
opk
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
05:41 pm
opk
OPKO Health: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
OPKO Health: Q4 Earnings Snapshot [Yahoo! Finance]
2/26
04:22 pm
opk
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results [Yahoo! Finance]
Neutral
Report
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results [Yahoo! Finance]
2/26
04:05 pm
opk
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Low
Report
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
2/23
01:04 pm
opk
GeneDx rises on Q4 beats, reiterating 2026 revenue guidance [Seeking Alpha]
Low
Report
GeneDx rises on Q4 beats, reiterating 2026 revenue guidance [Seeking Alpha]
2/23
12:23 pm
opk
GeneDx Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
GeneDx Q4 Earnings Call Highlights [Yahoo! Finance]
2/23
06:46 am
opk
GeneDx Holdings Non-GAAP EPS of $0.18 beats by $0.06, revenue of $121M beats by $0.56M [Seeking Alpha]
Medium
Report
GeneDx Holdings Non-GAAP EPS of $0.18 beats by $0.06, revenue of $121M beats by $0.56M [Seeking Alpha]
2/17
09:02 pm
opk
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation [Yahoo! Finance]
Low
Report
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation [Yahoo! Finance]
2/12
08:12 am
opk
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 [Yahoo! Finance]
Low
Report
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 [Yahoo! Finance]
2/12
08:00 am
opk
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
Medium
Report
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
2/10
06:01 am
opk
Florida law models what genetic disease testing could be [CNBC]
Neutral
Report
Florida law models what genetic disease testing could be [CNBC]
2/4
08:29 am
opk
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism [Yahoo! Finance]
Low
Report
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism [Yahoo! Finance]
2/4
08:00 am
opk
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Low
Report
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism